Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated?
- 1 February 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 43 (3) , 587-590
- https://doi.org/10.1016/s0360-3016(98)00434-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Urinary morbidity following ultrasound-guided transperineal prostate seed implantationInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Brachytherapy alone for early stage prostate cancer — Part I: Patient selection and technique and brachytherapy for early prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinomaCancer, 1997
- A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaCancer, 1997
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and RatiosJournal of Urology, 1995
- Prostate-specific antigen and radiation therapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.Journal of Clinical Oncology, 1995
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- Normal Histology of the ProstateThe American Journal of Surgical Pathology, 1988